Clinical Trial Update: LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial update on LSD treatment for anxiety symptoms in somatic disease or psychiatric anxiety disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Patients, Anxiety Disorders | Phase 2 | Status: COMPLETED